Irish bookings to US recover into 2026 following sharp fall
Irish bookings to the US are strong into 2026, according to the industry, following a brief collapse in travel across Europe widely attributed to political tensions and concerns over border controls.
'We did see a fall-off in bookings initially for the States [earlier in the year], but that has come back again,' said Ray Scully, managing director of American Holidays.
Airlines reacted to softening demand with price discounts, while the exchange rate has also improved. Mr Scully said trading was about flat for the year, but bookings from October and into 2026 were now strong.
'I think people want to go to the States. So it's putting off the decision is what it looked like as opposed to, we're not going to travel,' he said of the recent lull.
READ MORE
The collapse in arrivals to the US from across Europe during March was widely perceived as a reflection of antipathy to the policies of the Trump administration.
However, in Ireland at least, where
travel to the US dropped 27 per cent at the end of the first quarter
, data from the International Trade Administration (ITA) shows a 34 per cent bounce year on year for April.
The steep turnaround has been put down to a number of factors influencing travel decisions, including a levelling off in sentiment on US politics and the fact that Easter fell at the end of March, disrupting comparative data.
Eoghan Corry, editor of TravelExtra, noted that, as well as an increase in flight seats, Irish people are generally less inclined to stop visiting the US than other nationalities.
'So we are a little bit of an outlier in that we're probably a bit more resilient as a market to the negative publicity and the fears about US border control,' he said.
'The UK [which jumped 15 per cent in April] is more resilient as well because we're [both] very familiar with America. We don't see the Trump thing as being a game changer because all our cousins are there and we like people there and we're used to going over.'
He noted that Ireland's 34 per cent bounce was not replicated across all European markets, despite countries such as France (down 12 per cent) having similar aviation timetables and Easter holidays.
Overall passenger traffic from western European countries to the US dropped 17 per cent in March, according to the ITA, but that has bounced back and was up 12 per cent for April.
The volte-face will be welcome news to US tourism following sharp commentary that came on foot of the March declines.
Research firm Oxford Economics had said the fall-off in travel was attributable to an intensified 'America First' stance and the later timing of Easter.
'Policies and pronouncements from the Trump administration have contributed to a growing wave of negative sentiment,' it said. 'Heightened border security measures and visible immigration enforcement actions are amplifying concerns.'
Hashtags
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
The Journal
2 hours ago
- The Journal
Political parties scramble to introduce policies around AI use after Swedish House Mafia-gate
IRISH POLITICAL PARTIES are beginning to develop policies around the use of artificial intelligence (AI) after MEP Ciaran Mullooly revealed he used it to write a letter to the President of the European Commission. In the letter, which urged the EU to deliver more aid to Gaza, the Independent Ireland MEP inadvertently quoted the house music group Swedish House Mafia and recounted a fictional story of a girl in Rafah without indicating that she was not real. Following this, The Journal contacted all political parties represented in Dáil Éireann to see if they have policies or guidelines in place around the use of AI for public representatives. No party currently does. While the Labour Party said it has been working on guidelines since earlier this year, other parties were left scrambling after Mullooly's AI-assisted letter made headlines. The Social Democrats, Fine Gael and Independent Ireland all said they are currently working on developing policies, while the Green Party is also examining the idea as part of a strategic plan. A Sinn Féin source admitted that the Mullooly story was sent around to TDs as a 'cautionary tale' but said the party does not currently have any guidelines around the use of AI. Despite the slow uptake from political HQs on the issue, many TDs were more vocal about their feelings on the use of the technology in public life. When asked if they use AI to assist their work as a TD, just four current members of the Dáil admitted that they do. Independent TD Barry Heneghan used AI to create a song as part of his election campaign and said he uses a mix of programmes now as a TD, such as ChatGPT and Microsoft 365 Co-pilot, depending on the work he wants to streamline. Fianna Fáil's Paul McAuliffe, Fine Gael's John Paul O'Shea and Labour's Conor Sheehan all said they use programmes like ChatGPT and Co-pilot on occasion to help with admin tasks, but all were of the view that it shouldn't be used for drafting speeches or public statements. Advertisement 'I think transparency is important in this job. It's still up to TDs to stand over what they say and do, and AI can make mistakes and add things in that you would never say,' Heneghan said. He added: 'If you trusted it for your whole speech, it doesn't sound human in my opinion.' Independent Ireland TD Ken O'Flynn compared AI to the printing press and said his party supports the 'responsible use' of the emerging technology. 'Whether to improve communication or streamline workflows, like the printing press or the personal computer, artificial intelligence may face scepticism in its early stages but if history has shown us anything, it is that new tools often begin with controversy and end with positive transformation.' Most other TDs we contacted said they do not use AI to assist with their work, although many parties said staff sometimes use it for research purposes or admin. When asked if politicians should have to disclose when they have used AI to draft a speech or statement, most TDs we contacted said yes. A spokesperson for Independent Ireland said it 'would not be a bad idea in the interests of transparency', while Green Party leader Roderic O'Gorman went further and said it should also be disclosed when politicians use it to alter images of themselves. A number of TDs said it came down to being honest with constituents, while others, like People Before Profit TD Paul Murphy, said he was against its use on environmental grounds. Labour TD Duncan Smith argued that it is lazy for TDs to use AI. The Dublin Fingal East TD said he doesn't use it because he has 'no interest in selling my constituents short'. 'When people elect you to represent them, it should actually be you and the team you put together to work with you, representing your constituents. 'I think TDs using AI are displaying laziness at best and I think it shows a lack of respect to the people who have elected you to the Dáil, who rightfully expect you to be putting in the work,' he said. Readers like you are keeping these stories free for everyone... A mix of advertising and supporting contributions helps keep paywalls away from valuable information like this article. Over 5,000 readers like you have already stepped up and support us with a monthly payment or a once-off donation. Learn More Support The Journal
Irish Times
3 hours ago
- Irish Times
Letters to the Editor, June 23rd: On the EU and Israel, organ donation and tattoos
Sir, – Today, the EU foreign ministers are to meet to discuss whether the EU-Israel Association Agreement should be suspended, in whole or part, due to Israel's failure to meet human rights obligations. The review recommendations indicate Israel has failed to meet their human rights obligations, as they relate to their actions in Gaza. And yet all indications are that because there will not be consensus among the EU foreign ministers, they will provide a further month to see if Israel will change its posture on provision of aid to Gaza. This approach beggars belief. For the past 20 months Israel has faced innumerable 'red lines' from world governments and bodies, and ignored them with impunity. READ MORE On May 19th, Canada, France and the UK indicated there would be 'concrete actions' if Israel did not permit aid entering Gaza – we still await! On June 10th Australia, the UK, Canada, New Zealand and Norway placed financial sanctions and travel bans on two Israeli government ministers Itamar Ben-Gvir (national security minister), and Bezalel Smotrich (finance minister) – big swing! Yet every time it appears that taking firm action is close, Israel changes the narrative; the latest 'Israel is threatened by Iran', and the world shrinks back to the position of 'Israel has the right to defend itself'. While this occurs, Gaza slips further from public consciousness. The result being the killing and starvation continues unabated, and where aid posts appear to have become the new killing fields for the IDF. The EU foreign ministers must act with decisiveness today. Similarly, equally decisive action must come from EU leaders on Thursday. Failure to do so will indicate the EU leaders and politicians, our leaders, have parked their humanity. – Yours, etc, PHILIP BRADY, Donnycarney, Dublin 9. Sir, – Jane Mahony suggests in her letter (June 20th) that Trinity College is anti-Semitic and racist for singling out Israel, while maintaining ties with other unnamed countries with well documented human rights and international law violations. To suggest what Israel is doing in Gaza is comparable to what other unnamed countries are doing is a gross understatement of the atrocities Israel is carrying out on a daily basis. The slaughter of civilians, the destruction of homes and infrastructure, and the constant dehumanisation of Palestinians, are actions which Israelis and Israel's supporters should be ashamed of. Trinity's actions will at a minimum help to raise awareness with some Israelis of what their government are doing, while conveying the horror of many of us as we continue to watch the atrocities unfold. In the grand scheme of things, a small but brave step – the world could do with more of these. Yours, etc, MARTIN FOLAN, Leixlip, Co Kildare. New rules on organ donation Sir, – The new rules underpinning organ donation and transplant in Ireland, on which matter I was kindly quoted in a report online (' What are the new rules around organ donation in Ireland and what if I want to opt out ?', June 17th) are welcome but, as as observed by Dr Liam O'Neill (Letters, June 20th), are unlikely to boost activity in this literally vital realm. There is indeed a logical argument that they might reduce it. At present, ICU doctors aim to seek family consent from all potential organ donors and data shows that we largely achieve this. Henceforth, we will only seek consent in the case of patients not on the register. It is not obvious that significantly higher rates of acquiescence will result from these fewer requests. The point made by Dr O'Neill that, to match the best in the world, which he sees as 'the Spanish system', will require 'higher levels of Government support, investment and transplant infrastructure' is fair but there are cultural factors that also apply. Ireland is a very litigious society and this discourages doctors from taking on high-risk cases. This is a rational viewpoint that runs through our practice but that is not conducive to pushing the limits of medical innovation. We doctors may need to become braver. Another trend in recent years is that life-expectancy in Ireland has increased significantly, with safer roads and better outcomes from stroke among the factors. These disasters were major sources of donor organs. The consideration of older, less robust donors is becoming necessary. Notably, in recent years the US has soared in terms of international transplant activity reports. This appears to be good news, but the unfortunate reality is that the opioid epidemic there which has caused so many deaths has been the source of many donations. One must recall that organ donation is underpinned by tragic deaths of donors, and so be careful what we wish for. The priority of preventing those deaths in the first place is surely the most fundamental one. However, given the altruism of Irish people there is much to be optimistic about and I have no doubt we can achieve higher levels of transplantation. Investment in ICU beds and better theatre access are key targets. Currently, organ donation is the outcome of about 0.3 per cent of deaths it Ireland, and about 0.6 per cent of those in Spain. Approximating the rates of the latter country would enable us to greatly reduce waiting lists and improve quality of life, most markedly for those on dialysis. The new rules introduced will be merely a small step toward achieving this goal. The consideration of higher-risk donors is essential. – Yours, etc, BRIAN O'BRIEN, Kinsale, Co Cork. Tattoos, you lose Sir – I am not surprised to read that Gen-Z ( late 1990s and early 2010) are miserable according to Finn Mc Redmond. ( 'It's no wonder people my age are miserable. Everyone keeps telling them they're totally screwed,' June 19th) . When they look at their young bodies defaced with multiple tattoos, it cannot fill them with joy. Years ago the only people with tattoos were male prisoners , sailors and psychiatric patients. Now the young people of Generation Z have followed in their footsteps and those of the primitive tribes where this practice originated . I have yet to meet a person who did not regret getting a tattoo in later years . – Yours, etc, DR PAT Mc GRATH, Co Dublin. Sir, – I am not a great fan of tattoos, but one fascinated me a few days ago. A young man, out for a run overtook me. He was wearing shorts but no top. His entire back was covered in tattoos and I wondered where was the point, as obviously he couldn't see them , unless, of course, he has set up a double mirror at home. If so, I hope he enjoys his reflection after his run! – Yours. etc. MARGARET BUTLER, Co Dublin. Brain injury and better care Sir, – I refer to the letter from Joe Condon (June 14th) regarding the placement of younger people with disabilities in nursing homes. I want to endorse his call for the Government to take a leadership role in actively addressing this significant and enduring issue. An estimated 19,000 people in Ireland suffer a life-changing brain injury every year – that's 52 people every day, of all ages, from all corners of the country. Often, the impacts make it impossible for the person to return home directly from hospital and – for too many – the only available option is to live in a nursing home designed for the care of older people. As Mr Condon rightly asserts, this is not a place where a young person with a brain injury can engage effectively in rehabilitation to maximise their recovery and independence. Investing in community-based neuro-rehabilitation services is key to the solution. Rehabilitation services enable people with brain injury to move more seamlessly and successfully from hospital to home. They focus on ensuring that the person can rebuild their life after injury, reducing their limitations over time, promoting autonomy and community integration. Specialist brain injury case managers are essential to the rehabilitation process and critical to the realisation of the recommendations in the 2021 Wasted Lives report. They act as the bridge between acute hospitals, rehabilitation services, and community supports, making sure that no one with a brain injury is left to face their recovery alone – or worse, that they fall through the cracks and are forgotten about. They work in partnership to identify inappropriate nursing home placements, develop alternative pathways to recovery, and support young survivors of brain injury to move from residential care to more independent living. Some of those young people go on to work and further education. All of them – when they have the opportunity – return to play active roles and contribute to their communities. Currently, access to specialist brain injury case management is limited by geography. It is, in essence, an Eircode lottery. Acquired Brain injury Ireland is actively campaigning for an investment of €2 million per annum to provide this service nationwide. Not only would this targeted investment directly support commitments made in the programme for government to end the systemic misplacement of younger people in nursing homes – it would also uphold Ireland's obligations under the United Nations Convention on the Rights of Persons with Disabilities, which affirms the right of every person to access timely, appropriate rehabilitation. Brain injury can happen in the blink of an eye. Lives are changed, but not ended. We can do better. – Yours, etc, KAREN FOLEY, Chief executive , Acquired Brain Injury Ireland, Dublin. Infrastructure for cyclists Sir, – On my cycle to work in Galway University Hospital each day I pass through a number of new and under-construction housing developments in the Letteragh area, providing much needed modern urban housing for the people of Galway. What can't be seen anywhere are new protected cycle lanes or bus stops to accompany this rapid expansion of housing. Enforcing car dependency, through lack of active travel infrastructure, on a new generation of residents is both regressive and short-sighted. Galway already suffers from some of the worst congestion in Europe, adding thousands of cars to the picture can only worsen this. Located just 3km and 15 minutes by bike from the city centre, linking these new developments (and all those like it) to the city centre with active and public travel infrastructure should be a mandatory requirement for councils and developers. If we are serious about reducing congestion, improving our air pollution and health and meeting our legally binding emissions reductions targets, these are the open goals which we can't afford to miss. – Yours, etc, DR CALLUM SWIFT, Galway University Hospital, Galway. .
Irish Examiner
3 hours ago
- Irish Examiner
John Whelan: Ireland behind the curve in pharma R&D amid Pfizer call
Pharma companies met with the Trump administration earlier this month to try and defer implementation of the executive order signed by President Trump on May 12, effectively forcing drug companies to commit to aligning their US prices with 'the lowest price of a set of economic peer countries''. At the meeting of the Pharmaceutical Research and Manufacturers of America (PhRMA) with the Trump administration, Pfizer chief executive Albert Bourla called for the US government to lead an initiative to increase overall drug spending outside the US. While the exact mechanism of implementing the Trump executive order to reduce drug prices in the US remains unclear, the Pfizer chief proposed an alternative solution, suggesting that other countries should spend a certain percentage of their GDP per capita on innovative medicines. In an attempt to lead on the recommendation, he added that Pfizer could consider not making its drugs available for government reimbursement in some countries if the US carries through on its price control and other countries don't increase their prices. Effectively, Mr Bourla, who chairs the pharma industry lobby group PhRMA, suggested the US should push for a Nato-type agreement, which commits each country to a minimum 2% of their national GDP on defence spending. And whereas there may be good logic in the Pfizer proposal, any commitment of this nature will likely create major challenges for Ireland, as OECD and World Bank figures show Ireland lagging well behind other countries in research and development expenditure. In 2022, the last year for which finalised figures have been released, US pharmaceutical companies' R&D spending amounted to 2.33% of the nation's GDP. There is no comparable figures for the Irish market, in terms of pharmaceutical industry expenditure in research and development. However, the figures available from the World Bank and the OECD for years 2022/2023 show that total R&D for all industry as a percentage of GDP, in Ireland was 0.9%. This is well below the EU average of 2.29%, and even further below countries like the US at 3.6% and Israel at 6.3% who invest more heavily in R&D than Ireland. Economists have inferred that Trump is leveraging unfavourable policies such as drastically lowering prices points of US drugs and tariffs on imports, to coerce the pharmaceutical industry to increase investments in the US. Several large pharma companies, including Eli Lilly, Merck & Co, and Bristol Myers Squibb, have unveiled major US investments planned for the next few years in attempt to curry favour with the Trump administration. But noticeably Pfizer remains an exception to that trend. However, Mr Bourla stated that Pfizer has invested in US manufacturing and will continue to do so, but risks from those Trump policies are making it difficult for the company to commit further. "I don't think it makes sense to make announcements of future investments in an environment that is very fluid,' Mr Bourla said. That suggests Pfizer, one of our largest and longest-term investors in the pharmaceuticals space, is unlikely to back off its Irish investments anytime soon. However , we need to heed the Pfizer CEO's call for more R&D support in Europe, which clearly includes Ireland. Besides Pfizer, many pharma companies are leveraging the United States' threat of tariffs on drug imports to push for policy changes in the EU. In a letter sent on April 11 to European Commission President Ursula von der Leyen, 32 pharma companies demanded more favourable policies in order for them to maintain operations in the EU . In the same letter they say that policy changes are needed to ensure Europe remains a location to research, develop, and manufacture medicines. The CEOs also included in their letter that European countries should rethink their drug pricing policies and enable a better commercial environment for innovative medicines. Ireland's Research and Innovation Act 2024 , replaces Science Foundation Ireland in an attempt to fast forward the provision for the funding of research and innovation, but this caters for all fields of activity and neither commits to double the level of funding to €2bn per year needed to reach EU level, nor does it commit to meet the specific requirements of the pharma industry.
